title: The morbidity and mortality of patients with fungal infections before and during extracorporeal membrane oxygenation support.
abstract: OBJECTIVE
  To evaluate the prevalence of fungal infections (both pre-cannulation and post-cannulation) while on extracorporeal membrane oxygenation support and the associated morbidity and mortality.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  The Extracorporeal Life Support Organization database is an international voluntary registry of clinical data for patients placed on extracorporeal membrane oxygenation. The database was queried for all patients on extracorporeal membrane oxygenation from 1997 to 2009. Patient and extracorporeal membrane oxygenation data collected included age, support type, length of support, infection status and organism code, discharge status, complications, and component failures. Outcomes of interest were mortality, extracorporeal membrane oxygenation-related patient complications, and mechanical component failures.
  
  
  RESULTS
  From 1997 to 2009, there were 21,073 patients' extracorporeal membrane oxygenation runs analyzed of which 12,933 were in the neonatal group (0-30 days), 6,073 were in the pediatric group (31 days to <18 yrs old), and 2,067 were in the adult group (≥18 yrs). The prevalence of fungal infection during extracorporeal membrane oxygenation varied by age group and timing of infection and ranged from 0.04% to 5%. Fungal infections pre-extracorporeal membrane oxygenation and on-extracorporeal membrane oxygenation conferred a statistically significant higher relative risk of mortality for all age groups and varied by support type and timing of infection. Extracorporeal membrane oxygenation-related complications and component failures were not statistically significantly affected by infection status.
  
  
  CONCLUSIONS
  Fungal infection before or during extracorporeal membrane oxygenation increases the odds of mortality and the magnitude of this effect is dependent upon age-group and timing of infection. This increased mortality was not the result of increased patient or mechanical complications during extracorporeal membrane oxygenation. For patients with fungal infections pre-extracorporeal membrane oxygenation, 82%-89% demonstrated presumed clearance during extracorporeal membrane oxygenation. Although the risk of mortality increased with fungal infections, it does not appear that fungal infection before or during extracorporeal membrane oxygenation is a contraindication to initiation or continuation of support.
authors: Department of Pediatrics, Division of Critical Care, Vanderbilt University School of Medicine, Nashville, TN, USA.
authors: Thomas
authors: T
authors: Pluim
authors: Natasha
authors: N
authors: Halasa
authors: Sharon E
authors: SE
authors: Phillips
authors: Geoffrey
authors: G
authors: Fleming
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002177:Candidiasis / Q000401:mortality; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000401:mortality*; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009181:Mycoses / Q000145:classification / Q000401:mortality*; D015995:Prevalence; D012042:Registries; D012131:Respiratory Insufficiency / Q000628:therapy; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D013997:Time Factors; D014481:United States / Q000453:epidemiology; D055815:Young Adult